Rheumatoid arthritis and p53: How oxidative stress, might alter the course of inflammatory diseases

Immunology Today

Volumn 21, Issue 2, 2000, Pages 78-82

  Tak, Paul P ^a   Zvaifler, Nathan J ^b   Firestein, Gary S ^b   Greene, Douglas R ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; REACTIVE OXYGEN METABOLITE;

AUTOIMMUNITY; CHRONIC INFLAMMATION; DISEASE COURSE; DNA DAMAGE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENOTOXICITY; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TUMOR SUPPRESSOR GENE;

EID: 0034142176     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(99)01552-2     Document Type: Note

References (49)

1. 1 Firestein, G.S. (1996) Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum. 39, 1781-1790
2. 2 Lafyatis, R. et al. (1989) Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J. Clin. Invest. 83, 1267-1276
3. 3 Qu, Z.H. et al. (1994) Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia - results of proliferation cell nuclear antigen/cyclin, C-myc, and nucleolar organizer region staining. Arthritis Rheum. 37, 212-220
4. 4 Imamura, F. et al. (1998) Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthritis Rheum. 41, 1979-1986
5. 5 Muller-Ladner, U. et al. (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149, 1607-1615
6. 6 Ohshima, H. and Bartsch, H. (1994) Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305, 253-264
7. 7 Sionov, R.V. and Haupt, Y. (1998) Apoptosis by p53: mechanisms, regulation, and clinical implications. Springer Semin. Immunopathol. 19, 345-362
8. 8 Mapp, P.I. et al. (1995) Hypoxia, oxidative stress and rheumatoid arthritis. Br. Med. Bull. 51, 419-436
9. 9 Halliwell, B. (1995) Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann. Rheum. Dis. 54, 505-510
10. 10 Bashir, S. et al. (1993) Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann. Rheum. Dis. 52, 659-666
11. 11 McInnes, I.B. et al. (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med. 184, 1519-1524
12. 12 Farrell, A.J. et al. (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51, 1219-1222
13. 13 Grabowski, P.S. et al. (1996) Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate:creatinine ratio. Arthritis Rheum. 39, 643-647
14. 14 Witko-Sarsat, V. et al. (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J. Immunol. 161, 2524-2532
15. 15 Zhuang, J. et al. (1998) Mutagenesis associated with nitric oxide production in macrophages. Proc. Natl. Acad. Sci. U. S. A. 95, 8286-8291
16. 16 Driscoll, K.E. et al. (1996) Pulmonary inflammatory, chemokine, and mutagenic responses in rats after subchronic inhalation of carbon black. Toxicol. Appl. Pharmacol. 136, 372-380
17. 17 Lih-Brody, L. et al. (1996) Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig. Dis. Sci. 41, 2078-2086
18. 18 Forrester, K. et al. (1996) Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. U. S. A. 93, 2442-2447
19. 19 Antoniades, H.N. et al. (1994) p53 expression during normal tissue regeneration in response to acute cutaneous injury in swine. J. Clin. Invest. 93, 2206-2214
20. 20 Firestein, G.S. et al. (1996) Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am. J. Pathol. 149, 2143-2151
21. 21 Tak, P.P. et al. (1999) p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis. Arthritis Rheum. 42, 948-953
22. 22 Celli, A. and Que, F.G. (1998) Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma. Semin. Liver Dis. 18, 177-185
23. 23 Shibata, A. et al. (1994) Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis 15, 1085-1087
24. 24 Warren, W. et al. (1995) Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis 16, 1181-1189
25. 25 Bringuier, P. et al. (1998) Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymes. Int. J. Cancer 79, 531-536
26. 26 Kuwano, K. et al. (1996) P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 154, 477-483
27. 27 Lang, S.M. et al. (1997) Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis. Am. J. Gastroenterol. 92, 2166-2170
28. 28 Hibi, K. et al. (1997) Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am. J. Clin. Pathol. 108, 26-34
29. 29 Firestein, G.S. et al. (1995) Apoptosis in rheumatoid arthritis synovium. J. Clin. Invest. 96, 1631-1638
30. 30 Tak, P.P. and Firestein, G.S. (1999) Apoptosis and Inflammation (Winkler, J.D., ed.), pp. 149-162, Birkhauser Publishing
31. 31 Firestein, G.S. et al. (1997) Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. U. S. A. 94, 10895-10900
32. 32 Reme, T. et al. (1998) Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin. Exp. Immunol. 111, 353-358
33. 33 Kullmann, F. et al. (1999) Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 42, 1594-1600
34. 34 Han, Z. et al. (1999) Dominant negative p53 mutations in rheumatoid arthritis. Arthritis Rheum. 42, 1088-1092
35. 35 Aupperle, K.R. et al. (1998) Regulation of synoviocyte proliferation, apoptosis and invasion by the p53 tumor suppressor gene. Am. J. Pathol. 152, 1091-1098
36. 36 Graeber, T.G. et al. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91
37. 37 Ziegler, A. et al. (1994) Sunburn and p53 in the onset of skin cancer. Nature 372, 773-776
38. 38 Sun, Y.B. et al. (1999) p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression. J. Biol. Chem. 274, 11535-11540
39. 39 Ladiwala, U. et al. (1999) p53 induction by tumor necrosis factor-alpha and involvement of p53 in cell death of human oligodendrocytes. J. Neurochem. 73, 605-611
40. 40 Leri, A. et al. (1999) Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. Am. J. Pathol. 154, 567-580
41. 41 Cannons, J.L. et al. (1998) HPRT-mutant T cells in the peripheral blood and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 41, 1772-1782
42. 42 Roivainen, A. et al. (1997) H-ras oncogene point mutations in arthritic synovium. Arthritis Rheum. 40, 1636-1643
43. 43 Ihling, C. et al. (1997) Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler. Thromb. Vasc. Biol. 17, 2218-2224
44. 44 Krishna, M. et al. (1995) Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Mod. Pathol. 8, 654-657
45. 45 Maacke, H. et al. (1997) Overexpression of p53 protein during pancreatitis. Br. J. Cancer 75, 1501-1504
46. 46 Islam, D. et al. (1997) In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. Infect. Immun. 65, 739-749
47. 47 Okayasu, I. et al. (1998) p53 and p21(WAF1) expression in lymphocytic thyroiditis and thyroid tumors. Clin. Immunol. Immunopathol. 88, 183-191
48. 48 Nickels, A. et al. (1997) Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment. J. Clin. Pathol. 50, 654-660
49. 49 Maurice, M.M. et al. (1999) Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum. 42, 2430-2439